"Aromatase inhibitors" trang 1 - tải miễn phí từ tailieunhanh
Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer

Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer
9    58    1
Đánh giá chất lượng cuộc sống và tình trạng đau khớp trên bệnh nhân ung thư vú điều trị Aromatase inhibitor tại Trung tâm Ung Bướu Thái Nguyên

Đánh giá chất lượng cuộc sống và tình trạng đau khớp trên bệnh nhân ung thư vú điều trị Aromatase inhibitor tại Trung tâm Ung Bướu Thái Nguyên
9    16    1
Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: Study protocol of a randomised controlled trial to evaluate the effect of short message service (SMS) reminder

Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: Study protocol of a randomised controlled trial to evaluate the effect of short message service (SMS) reminder
9    97    0
Pyrotinib with trastuzumab and aromatase inhibitors as first-line treatment for HER2 positive and hormone receptor positive metastatic or locally advanced breast cancer: Study protocol of a randomized controlled trial

Pyrotinib with trastuzumab and aromatase inhibitors as first-line treatment for HER2 positive and hormone receptor positive metastatic or locally advanced breast cancer: Study protocol of a randomized controlled trial
6    60    1
An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients

An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients
9    29    1
Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells

Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells
15    33    1
CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients

CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients
12    69    1
Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors

Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors
7    58    1
Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment - the COMPAS study

Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment - the COMPAS study
9    58    1
Vertebral bone marrow fat fraction changes in postmenopausal women with breast cancer receiving combined aromatase inhibitor and bisphosphonate therapy

Vertebral bone marrow fat fraction changes in postmenopausal women with breast cancer receiving combined aromatase inhibitor and bisphosphonate therapy
7    39    1
Anti-masculinization induced by aromatase inhibitors in adult female zebrafish

Anti-masculinization induced by aromatase inhibitors in adult female zebrafish
10    37    2
Đánh giá chất lượng cuộc sống ở bệnh nhân ung thư vú điều trị bằng thuốc ức chế aromatase inhibitor tại Trung tâm Ung bướu Thái Nguyên

Đánh giá chất lượng cuộc sống ở bệnh nhân ung thư vú điều trị bằng thuốc ức chế aromatase inhibitor tại Trung tâm Ung bướu Thái Nguyên
8    42    2
Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): Study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial

Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): Study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial
12    19    1
Promoting physical activity through supervised vs motivational behavior change interventions in breast cancer survivors on aromatase inhibitors (PAC-WOMAN): Protocol for a 3-arm pragmatic randomized controlled trial

Promoting physical activity through supervised vs motivational behavior change interventions in breast cancer survivors on aromatase inhibitors (PAC-WOMAN): Protocol for a 3-arm pragmatic randomized controlled trial
17    1    1
Aromatase inhibitors induced autoimmune disorders in patients with breast cancer: A review

Aromatase inhibitors induced autoimmune disorders in patients with breast cancer: A review
8    89    0
Aromatase inhibitors and risk of cardiovascular events in breast cancer patients: A systematic review and metaanalysis

Aromatase inhibitors and risk of cardiovascular events in breast cancer patients: A systematic review and metaanalysis
11    72    0
Báo cáo y học:

Báo cáo y học: "Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo"
9    44    0
Breast Cancer: Prognosis, Treatment, and Prevention Second Edition

Breast Cancer: Prognosis, Treatment, and Prevention Second Edition
609    52    0
Báo cáo y học:

Báo cáo y học: "Association Study of Aromatase Gene (CYP19A1) in Essential Hypertension"
7    45    0
Báo cáo khoa học:

Báo cáo khoa học: "Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration"
11    45    0